Researchers are reporting that a new vaccine designed to treat breast cancer appears to be safe in women with advanced disease. It showed signs of slowing down tumor growth too.

The Neuvenge vaccine, made by Dendreon Corporation -- maker of the Provenge prostate cancer vaccine -- targets the aggressive Her-2 positive form of breast cancer, which affects 20 to 30 percent of breast cancer patients. Using immune cells from a cancer patient's own body, Neuvenge is a tailor-made therapy.

Reports about Neuvenge, published in the Journal of Clinical Oncology, indicate the vaccine did not cause any serious side effects and of the 18 women who participated in the Phase I study, there was a reduction in the size of a tumor in one patient. In three other women, the disease seemed to stabilize for as long as a year.

George Mitchell, the man leading an independent investigation of steroid use among Major League Baseball players -- he's also a former U.S. Senate Majority Leader -- has been diagnosed with prostate cancer.

"The cancer is small, low grade and localized, and can be effectively treated and cured,'' says Mitchell's physician, The prognosis is very good for Mitchell, a Democrat from Maine.

Mitchell, 73, said in a statement that he expects his treatment will not interfere with his investigation that began in March 2006 when he was appointed by MLB Commissioner Bud Selig to interview hundreds of people and review thousands of documents.

When my husband told me today that Merv Griffin had died, I was running on my treadmill, doing my part to pound out any chance that cancer will pay me a return visit. On my MP3 player the song Bad Day by Daniel Powter was blaring. Sweating, halfway through my second mile and feeling quite strong, I heard the words -- "Did you hear Merv Griffin died?"

No, I had not yet heard. All I was hearing were these lyrics:

You had a bad day
The camera don't lie
You're coming back down and you really don't mind
You had a bad day
You had a bad day

Merv Griffin, creator and producer of TV game shows Jeopardy! and Wheel of Fortune, announced in July that he'd been diagnosed once again with prostate cancer. Hospitalized after the cancer recurrence was detected during a routine examination, Griffin was reportedly doing fine. New reports indicate Griffin's prognosis is not so fine, although his reps won't confirm of deny this.

It is clear Griffin is still in the hospital. Sources close to him say he is putting all his strength into fighting this battle with cancer.

In lieu of sending him flowers, Griffin asks that well-wishers donate to the Young Musicians Foundation -- an organization he chairs. Also, messages can be sent here.

Texas Longhorns running backs coach Ken Rucker will soon take a leave of absence, following his recent diagnosis of prostate cancer. Rucker will have surgery on August 27. He wll keep coaching until this date.

Rucker, a 33-year coaching veteran, fully intends on returning to coaching this season.

"I plan to be back this season," he says. "No doubt about it; 100 percent."

Rucker's prognosis is good -- thanks to early detection.

Original ABC Wide World of Sports announcer Bill Flemming, also known for broadcasting college football, golf, and Olympic events, died last Friday of prostate cancer. He was 80.

Before sports fans were watching televised football games all weekend long -- and then watching on-going highlights on ESPN -- they were listening to Fleming's Sunday afternoon run-down of the previous day's games. He offered fans a glimpse into matches from other regions, and he traveled all over these same regions if it meant capturing a story. He announced 11 Olympics and more than 600 Wide World of Sports events. He once shuttled from hurling in Ireland to car racing in Santa Monica, California, to a parachuting contest in Bavaria, all in just one month.

Named Norman Flemming on the day he was born in 1926, this man grew up in the Chicago area, moved to Ann Arbor, Michigan as a high school student, and was a member of Ann Arbor High School's state championship football team in 1943. He was also co-captain of the basketball team. He came by athletics naturally. Speech, his eventual college major, was another love. In 1949, he won a campus-wide speech contest and landed the grand prize: a summer job at WUOM, the campus radio station. He worked his way up to sports director. And then his career took off.

We all want an experienced surgeon, of course, but are you sure your surgeon is experienced enough?

In a recent article published in the Journal of the National Cancer Institute, patients with prostate cancer who have a prostatectomy performed by a more experienced surgeon tend to have better outcomes.

A prostatectomy involves removal of the prostate gland and surrounding tissue. A study was done to evaluate the total number of prostatectomies a surgeon has performed and if this indeed had influence on recurrence rates.

It seems so, patients who had a surgeon that performed less than 10 prior prostatectomies had a recurrence rate of 18 percent. Patients who had a surgeon that performed over 250 prostatectomies had recurrence rates of only 10 percent.

I think the take home message here is, no matter what kind of surgery you are getting -- ask your surgeon how many times they have done this specific procedure. If it seems very low you might want to consult another surgeon who has more experience.

Merv Griffin, inventor and producer of TV game shows Jeopardy! and Wheel of Fortune, has been hospitalized for a recurrence of prostate cancer. The cancer was discovered during a routine examination several weeks ago.

Now in Cedars-Sinai Medical Center, the 82-year-old Griffin says, "I'd rather play Jeopardy! than live it. I was ready for a vacation; however, this wasn't the destination I had in mind."

Griffin's son, Tony, said his father is getting great care. His medical team wants to monitor his progress in a controlled setting, he said, and that's why he's in the hospital.

According to TV Squad, Griffin has another game show in the works. Let's Play Crosswords will premiere in syndication across the country this fall.

Seventy year old Ronald Baker says that "its hard to think about cancer on a growling bulldozer". He was diagnosed with prostate cancer and receives radiation daily, where he says is the only time during the day he thinks about having cancer.

Baker enjoys driving the two ton bulldozer and feels that staying busy is keeping his mind off of his cancer diagnosis and treatments. When he isn't working Ronald stays at Jack's Place, a temporary home for people needing long-term cancer treatments.

Ronald lives with his wife on a secluded ranch in Colorado where he rides horses and takes people on guided hunting trips in the winter. There wasn't a good treatment center available where he lives so he was referred to Jack's Place, a place he could live and find a job to keep busy during his radiation treatments.

Way to go Ronald!

Major League Baseball and the Prostate Cancer Foundation teamed up this year to form the Home Run Challenge in honor of Father's Day. Their gift to father's across the country: for each home run hit in 60 selected games between June 6 and today, June 17, raised money for prostate cancer, the second most common cancer for men in the United States.

Some fans of this cause made pledges; some posted online tributes to their dads at Dockers San Francisco. For every message submitted, the company donated one dollar. Some messages were even shown in Times Square for all to see.

I just checked the status of the Home Run Challenge on this Father's Day morning and found the most updated total of home runs to be 91. Leading the accomplishment are Ken Griffey, Jr., Alex Rodriguez, and Alfonso Soriano. The current Team Home Run leader: the Cincinnati Reds.

First, it seemed eating lycopene-rich tomatoes offered protection against prostate cancer. Now it seems this is not so true. In fact, researchers have found an association between an increased risk of aggressive prostate cancer and beta carotene, an antioxidant related to lycopene.

Lycopene seemed for a short time to be a quick and easy fix for men trying to lower their prostate cancer risk. Yet studies are failing to show any significant differences in blood lycopene levels between men who develop the disease and those who do not.

The largest study to yield these results investigated the role of blood levels of lycopene and other antioxidants in the prevention of prostate cancer. It was an unexpected turn of events that led researchers to the link between the most aggressive cancers and antioxidants found in many vegetables. While the observation may be due to chance, beta carotene is known to increase risk of lung cancer and heart disease in smokers and may be worth a bit more study.

It's been suspected that taking too many vitamins may spike men's risk of dying from prostate cancer. On Wednesday, the biggest study yet to link high-dose multivitamins and prostate damage was published in the Journal of the National Cancer Institute.

Government scientists have been looking at the diet and health of almost 300,000 men. One third reported taking a daily multivitamin. Five percent were heavy users, marked by use more than seven times per week. Within five years of the study's launch, 10,241 men had been diagnosed with prostate cancer. About 1,476 had an advanced form of the disease. And 179 died.

It seems heavy multivitamin users were nearly twice as likely to get fatal prostate cancer as men who never took the pills. Yet, oddly, researchers found no link between multivitamin use and early-stage prostate cancer. It could be that vitamins have little effect until a tumor appears -- and then it spurs growth.

More studies are on the horizon for this topic, which is becoming more and more pressing.

The FDA was given the okay by their panel of advisors to approve the drug Provenge, an immunotherapy that stimulates the immune system to help fight cancer cells.

The drug is designed for patients with metastatic prostate cancer who stop responding to hormonal therapy. The drug triggers the immune system to recognize a particular protein that is found on about 95 percent of all prostate cancer cells. When the immune system identifies the protein, it attacks the cancer cells.

The drug has shown in two previous trials that it increases survival in patients that have prostate cancer that has spread to other parts of the body.

I never thought I'd hear this one -- that women whose tonsils were removed during childhood may be at increased risk of developing pre-menopausal breast cancer. But sure enough, that's what researchers at the University of Buffalo are reporting.

Think about this:

Researchers say the association between tonsillectomies and breast cancer may be related to the loss of protective function when tonsils are removed. Also, tonsils can be markers for infection in childhood. Some infections cause inflammation which can contribute to cancer. When the tonsils are gone, markers are gone.

Other studies have linked tonsillectomies with an increased risk of Hodgkin's lymphoma, leukemia, and breast and prostate cancers. This study, reported at the 100th annual meeting of the American Association of Cancer Research, confirms the breast cancer connection -- but further study is still necessary.

A reader posted a comment on one of my blogs and asked "What tests positively determines prostate cancer?" It prompted me to do a little research. 80 percent of men over 70 years old will get prostate cancer. That is a devastating statistic. A lot of times in the medical field diagnosing something requires a multitude of tests to rule out things and to get a better diagnosis. Such is the case for prostate cancer.

There are several tests used to diagnose prostate cancer. Blood tests, rectal exams, rectal ultrasounds, needle biopsy, and cystoscopy. A high level of PSA in the blood can be a sign of prostate cancer. PSA is a protein produced by cancerous prostate cells. With a rectal exam your doctor can feel for lumpy or a hard prostate. If a lump or hardening is found then most often they will do a needle biopsy to examine under a microscope. A cystoscopy is an examination of your bladder and uretha but can help determine several types of cancer and not just bladder cancer.

With all kinds of cancer, it is important to stay up to date with yearly exams for prevention. I hope this information helps.